| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/16/2001 | WO2001012172B1 Treatment of metastatic disease |
| 08/16/2001 | WO2001010893A3 Il-16 antagonists |
| 08/16/2001 | WO2001010891A3 Il-16 antagonists |
| 08/16/2001 | WO2001010413A3 Periodic structures comprising lipids, polyelectrolytes, and structures-inducing soluble oligovalent linkers |
| 08/16/2001 | WO2001009293A3 Mammalian adhesion protease peptides |
| 08/16/2001 | WO2001009185A3 Transmembrane transport proteins, nucleic acids encoding them and uses therefor |
| 08/16/2001 | WO2001009173A3 Use of quinic, shikimic acids and their derivatives for preparing mannose receptor ligands |
| 08/16/2001 | WO2001009115A3 A NOVEL CRYSTALLINE FORM OF 6-HYDROXY-3- (4-[2-(PIPERIDIN-1- YL)ETHOXY] PHENOXY)-2- (4-METHOXYPHENYL) BENZO[b]THIOPHENE HYDROCHLORIDE |
| 08/16/2001 | WO2001007628A3 Human synthetases |
| 08/16/2001 | WO2001007595A3 Novel fibroblast growth factor and nucleic acids encoding same |
| 08/16/2001 | WO2001006989A3 Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders |
| 08/16/2001 | WO2001004354A3 Use of ras inhibitors of inhibiting muscle atrophy |
| 08/16/2001 | WO2001002569A3 Human immune response molecules |
| 08/16/2001 | WO2001002556A3 Agents for the diagnosis, prognosis and treatment of malignant diseases |
| 08/16/2001 | WO2000058506A3 Susceptibility to psoriasis |
| 08/16/2001 | WO2000057866A3 Use of azalide antibiotics for the topical treatment or prevention of ocular infections |
| 08/16/2001 | WO2000049132A3 Uses of transgenic animals containing a type x collagen mutant |
| 08/16/2001 | WO2000046367A3 Proteins capable of triggering g2/m transition and of interacting with cdc2- and cyclin b |
| 08/16/2001 | WO2000044782B1 Ewing's tumour antigen, nucleic acid and antibodies |
| 08/16/2001 | WO2000029589A8 Methioninase gene therapy for tumor treatment |
| 08/16/2001 | WO1999064046A8 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-ht3 receptors |
| 08/16/2001 | WO1999050658A3 Methods and compounds for modulating nuclear receptor activity |
| 08/16/2001 | US20010014734 Controllers |
| 08/16/2001 | US20010014676 For mammals; mixture with drug |
| 08/16/2001 | US20010014674 Wound healing agent |
| 08/16/2001 | US20010014668 Colonization factor antigens; epitopes; immunization against diarrheagenic Escherichia |
| 08/16/2001 | US20010014666 Solution comprises purified glucagon-like peptide-1, buffering agent containing alcohol or mono/di- saccharide, and optionally ammonium sulfate; tetragonal flat rod shaped crystals formed; useful in treating diabetes and obesity |
| 08/16/2001 | US20010014665 For oral administration to reduce nephrotoxicity and topically promote skin permeation in treatment of psoriasis |
| 08/16/2001 | US20010014664 Viscosity; biodegradability; fibroblast growth factor |
| 08/16/2001 | US20010014663 Treatment of allograft rejection with anti-angiogenic agents |
| 08/16/2001 | US20010014476 Region which allows its replication comprises an origin of replication derived from a plasmid or a bacteriophage and whose functionality in the host cell requires the presence of at least one specific protein foreign to host cell |
| 08/16/2001 | US20010014474 Preparing hybridoma cell line which produces antibody which specifically recognizes and binds to cell surface antigen associated with a neoplastic human cell; diagnosis, therapy |
| 08/16/2001 | US20010014471 Antitumor agents |
| 08/16/2001 | US20010014465 Human 4-1BB receptor splicing variant |
| 08/16/2001 | US20010014464 Nucleic acid encoding follistatin-3 |
| 08/16/2001 | US20010014463 Lysozyme-like enzymes capable of killing cariogenic bacteria; also methods for studying the cell wall of oral bacterium, preventing spoilage of perishable items and removing dextrans from surfaces used in sugar refining |
| 08/16/2001 | US20010014458 Human G-protein coupled receptor GPR6sb |
| 08/16/2001 | US20010014342 Use of a substance P antagonist in a cosmetic composition, and the composition thus obtained |
| 08/16/2001 | US20010014337 A peptide having substantial homology with the CBF1/RBPJk (cell binding factor-1/recombination bining protein J kappa) interaction domain of EBNA2 comprising specific peptide containing 15-20 amino acids |
| 08/16/2001 | US20010014333 Hybrid heterodimeric protein hormone and method of using same |
| 08/16/2001 | US20010014328 A multispecific binding molecule, comprising a first binding determinant which binds an Fc alpha receptor is not blocked by human immunoglobin A and a second binding determinant binds target cancer cell antigen |
| 08/16/2001 | US20010014325 Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore |
| 08/16/2001 | US20010014323 For use in investigation, diagnosis and treatment of subjects suspected of or suffering from sulphamidase deficiency |
| 08/16/2001 | US20010014319 Defective recombinant virus containing at least one inserted gene encoding all or part of lecithin-cholesterol acyltransferase (LCAT) or a variant thereof; treating or preventing dyslipoproteinaemia-related diseases |
| 08/16/2001 | EP1144997A3 Methods and compounds for modulating nuclear receptor activity |
| 08/16/2001 | EP1144678A3 Susceptibility to psoriasis |
| 08/16/2001 | EP1144627A3 Proteins capable of triggering g2/m transition and of interacting with cdc2- and cyclin b |
| 08/16/2001 | EP1123717A2 Estrogen agonist/antagonist and statin containing compositions for treating osteoporosis and lowering cholesterol |
| 08/16/2001 | EP1123709A1 Preventives/remedies for liver diseases |
| 08/16/2001 | EP1123692A2 Use of polyaminoacid derivatives for the treatment of Seborrhea and related cutaneous disorders |
| 08/16/2001 | EP1123653A1 Use of polyamino acid derivatives as preservatives |
| 08/16/2001 | EP1123509A2 Methods of diagnosing or prognosing alzheimer's disease |
| 08/16/2001 | EP1123418A2 Isolated nucleic acid molecules which encode scp proteins, and uses thereof |
| 08/16/2001 | EP1123414A1 Antisense modulation of integrin alpha 4 expression |
| 08/16/2001 | EP1123401A1 BIOACTIVE PEPTIDES AND PEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHrP) |
| 08/16/2001 | EP1123397A2 G-protein coupled receptors |
| 08/16/2001 | EP1123395A2 Nucleic acids encoding osteoprotegerin-like proteins and methods of using same |
| 08/16/2001 | EP1123393A1 Follistatin-related protein zfsta2 |
| 08/16/2001 | EP1123392A1 Prv-1 gene and the use thereof |
| 08/16/2001 | EP1123390A2 Methods and reagents for isolating biologically active peptides |
| 08/16/2001 | EP1123387A2 Mn gene and protein |
| 08/16/2001 | EP1123315A1 Multiple domain glycoprotein hormones and methods of using |
| 08/16/2001 | EP1123314A2 USE OF A CYTOKINE-PRODUCING $i(LACTOCOCCUS) STRAIN TO TREAT COLITIS |
| 08/16/2001 | EP1123313A2 Methods and compositions for the prevention and treatment of anemia |
| 08/16/2001 | EP1123312A2 Human rna binding proteins |
| 08/16/2001 | EP1123309A2 Cyclic tetrapeptides and their use as histone deacetylase inhibitor |
| 08/16/2001 | EP1123306A1 Inhibitors of platelet activation and recruitment |
| 08/16/2001 | EP1123115A1 Treatment of trauma (ie graft rejection) with liposomes containing dna encoding for ctla4ig or for anti cd40l |
| 08/16/2001 | EP1123114A1 Virus-like particles for the induction of autoantibodies |
| 08/16/2001 | EP1123112A1 Ionic molecular conjugates of n-acylated derivatives of poly (2-amino-2-deoxy-d-glucose) and polypeptides |
| 08/16/2001 | EP1123111A1 Modulation of gene expression by combination therapy |
| 08/16/2001 | EP1123110A1 Compositions and methods for promoting tissue repair using heat shock proteins |
| 08/16/2001 | EP1123109A1 Contulakin-g, analogs thereof and uses therefor |
| 08/16/2001 | EP1123108A1 Isolated peptides which bind to hla-b35 molecules |
| 08/16/2001 | EP1123090A1 Method and composition for modulating amyloidosis |
| 08/16/2001 | EP1123072A1 Anti-inflammatory and antimicrobial uses for bioactive glass compositions |
| 08/16/2001 | EP0805817B1 Thiol derivatives with metallopeptidase inhibitory activity |
| 08/16/2001 | EP0771189B1 Inhalation composition |
| 08/16/2001 | EP0759944B1 Target cell binding chimaeric peptides |
| 08/16/2001 | EP0749444B1 Hybrid human/animal factor viii |
| 08/16/2001 | EP0710247B1 Process for manufacture of 1-deamino-8-d-arginine vasopressin |
| 08/16/2001 | EP0702958B1 Vaginal preparation containing physiologically active peptide |
| 08/16/2001 | EP0694307B1 Atopic disease remedy |
| 08/16/2001 | EP0684820B1 Biologically active 3-substituted oxindole derivatives useful as anti-angiogenic agents |
| 08/16/2001 | EP0670729B1 Use of insulin-like growth factors and analogs for TREATING RETINAL NEURONAL DISORDERS |
| 08/16/2001 | EP0587639B1 Pharmaceutical compositions |
| 08/16/2001 | EP0576483B1 Biocidal proteins |
| 08/16/2001 | EP0552256B1 Method of treating or preventing type 1 diabetes by oral administration of insulin |
| 08/16/2001 | DE10004858A1 Verwendung von Proteinkinase-Inhibitor-alpha The use of protein kinase inhibitor alpha- |
| 08/16/2001 | DE10004857A1 MLP-Gen, Nukleinsäuren, Polypeptide und deren Verwendung MLP-gene nucleic acids, polypeptides and their use |
| 08/16/2001 | DE10004447A1 Verfahren zur Verhinderung von Tumorwachstum A method for preventing tumor growth |
| 08/16/2001 | CA2714081A1 Methods and compositions for treating conditions of the eye |
| 08/16/2001 | CA2635489A1 Drug delivery apparatus |
| 08/16/2001 | CA2400699A1 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
| 08/16/2001 | CA2400497A1 Methods and compositions for generating angiostatin |
| 08/16/2001 | CA2400472A1 Il-17 like molecules and uses thereof |
| 08/16/2001 | CA2400299A1 Dna encoding human vanilloid receptor vr3 |
| 08/16/2001 | CA2400187A1 Protein c derivatives |
| 08/16/2001 | CA2400186A1 Microencapsulation and sustained release of biologically active agent |
| 08/16/2001 | CA2399969A1 Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof |